Psoriasis patient’s mental health is more than skin-deep

 

Umeå, Sweden (June 4, 2020) — Treatment of the common disease psoriasis, usually focuses on treating the skin. However, psoriasis patients often have other physical diseases that can bring on depression, anxiety, and suicide. A new study from Umeå University, Sweden, shows that these other somatic diseases have even more impact on patients‘ mental health than their skin symptoms, highlighting the importance of holistic patient care.

Psoriasis is a lifelong disease. The body produces skin cells too quickly which build up on the skin’s surface in the form of inflamed red, painful, itchy scales. Many people with psoriasis have other physical diseases such as being overweight, diabetes and heart diseases.

„What we didn’t know before is how psoriasis skin symptoms and other somatic diseases associated with psoriasis impact mental health,“ says Marcus Schmitt-Egenolf, Dermatologist and Professor at Umeå University.

Previous research found that people with psoriasis suffer more often from somatic and mental diseases compared to individuals without psoriasis. A new study confirmed this. The study also investigated how psoriasis skin symptoms and associated somatic diseases impacted mental health, considering anxiety, depression and suicide together.

The study found that skin symptoms have an important impact on mental health, but that other somatic diseases associated with psoriasis can cause even more harm to mental health.

„We found that skin symptoms increased the risk of mental illness by a third, while other physical illnesses doubled the risk among psoriasis patients,“ says Kirk Geale, PhD candidate at Umeå University. The results in the study shows a 32 percent increase risk of mental illness caused by skin symptoms and a 109 percent increased risk at other somatic illnesses.

This information is important as the total burden of mental health burden for people with psoriasis, and what contributes to it, was not well established. The study’s findings encourage people with psoriasis to talk with their doctors more about symptoms beyond the skin, both physical and mental. It also encourages doctors to proactively discuss these issues with their patients.

„I would be delighted if our study could support the trend towards a more holistic view on psoriasis care. At the doctor’s office, lifestyle factors should be discussed in the awareness that individual responsiblity may be limited by available personal and community resources. Such an approach may improve the complete triad of psoriasis – skin symptoms, somatic and mental health alike,“ concludes Marcus Schmitt-Egenolf.

The study was conducted during 2017 – 2019. Nationwide data from about 100.000 individuals with psoriasis but without earlier mental diseases in Sweden were compared to a control group without psoriasis. The study is published in JAMA Dermatology.

 


Umea University, 20.04.2020 (tB).

Schlagwörter: , ,

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Nahrungsergänzungsmittel während der Krebstherapie: Es braucht mehr Bewusstsein für mögliche…
Fusobakterien und Krebs
Fortgeschrittenes Zervixkarzinom: Pembrolizumab verlängert Leben
Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…